|
| Status |
Public on May 03, 2021 |
| Title |
Intratumoral TFR cells curtail anti-PD-1 treatment efficacy |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| Web link |
https://doi.org/10.2139/ssrn.3596586
|
| |
|
| Citation(s) |
34168370 |
| Submission date |
Jun 06, 2019 |
| Last update date |
Aug 02, 2021 |
| Contact name |
Pandurangan Vijayanand |
| E-mail(s) |
vijay@lji.org
|
| Organization name |
La Jolla Institute for Allergy and Immunology
|
| Department |
Division of Vaccine Discovery
|
| Lab |
VD-Vijay
|
| Street address |
9420 Athena Circle
|
| City |
La Jolla |
| State/province |
California |
| ZIP/Postal code |
92037 |
| Country |
USA |
| |
|
| Platforms (3) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (62)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE132295 |
Intratumoral TFR cells curtail anti-PD-1 treatment efficacy [human] |
| GSE132296 |
Intratumoral TFR cells curtail anti-PD-1 treatment efficacy [mouse] |
|
| Relations |
| BioProject |
PRJNA547551 |
Less...
More...